Chronic Stress
Activates the stress HPA axis, driving sustained cortisol release, eroding sleep, immunity, and energy.
Chronic stress and gut imbalance fuel each other. Single-ingredient solutions break only one arm of the cycle.
Activates the stress HPA axis, driving sustained cortisol release, eroding sleep, immunity, and energy.
Cortisol shifts gut composition: beneficial bacteria decline, harmful pathogens expand.
A dysbiotic gut signals back to the brain, amplifying stress HPA tone the spiral continues. .
No mainstream ingredient recalibrates the stress HPA axis and selectively restores microbiome balance in a single dose. ThymoQuin does it all — at a 500 mg/day dose.
| Approach | What it targets | What it misses |
|---|---|---|
| Adaptogens (Ashwagandha, Rhodiola) | Primarily stress HPA axis and cortisol | The gut root cause + mood signaling |
| Probiotics | Gut microbiome | The stress response + mood signaling |
| Mood supplements (5-HTP, SAMe) | Brain neurotransmitters | The upstream gut and cortisol signals |
| ThymoQuin® | All three: Stress HPA, Microbiome, and the Immune-Neural Network that connects them | Nothing |
Inhibits NF-κB, TNF-α, and COX. Supports mitochondrial function and lowers oxidative stress.
Amplifies beneficial commensals and suppresses pathogens within a precise hormetic window. Supports the neural signaling that reaches the brain.
Sustained thymoquinone exposure restores cortisol-DHEA balance, sleep and mood, through the same gut-brain-immune communication network that connects the microbiome to psychological and physiological well-being.
All outcomes measured at 500 mg/day, across 4 to 8 weeks of daily supplementation.
↓ 23-44%
↑ 29%
(verified stress resilience adaptogenic signature)
53×
(S. thermophilus)
> 94%
(K. pneumoniae)
62%
(URTCs)
↑ 31%
↑ 11-27%
(POMS across Talbott 2022 and 2026)
↓ 11.2%
decrease of ↓12.2%
48h
In vitro · Papini et al. 2026
ThymoQuin operates inside a defined concentration window — 0.125% to 0.5% — where it amplifies beneficial bacteria and reduces opportunistic pathogens at the same time. Outside that window, selectivity is lost.
Swipe the chart sideways to see every concentration →
Vitality ratio as % of untreated control (dashed line = 100%). Bars marked ↑ exceed the axis and are clipped; their true value is printed above.
| Concentration | K. pneumoniae | L. plantarum | S. thermophilus | A. muciniphila |
|---|---|---|---|---|
| 0.031% | 82% | 112% | 163% | 111.7% ± 31.1 |
| 0.063% | 49% | 116% | 187% | 121.1% ± 21.9 |
| 0.125% | 49% | 107% | 508% | 102.3% ± 24.8 |
| 0.25% | 44% | 90% | 1726% | 89.9% ± 36.3 |
| 0.5% | 21% | 89% | 2718% | 77.4% ± 27.0 |
| 1.0% | 7% | 74% | 120% | 28.1% ± 15.8 |

At 500 mg/day, ThymoQuin® is the only clinically studied ingredient shown to dually support Stress HPA-axis regulation and selectively rebalance the gut microbiome two key pathways in the gut-stress axis.
Our team can help you position it in stress, sleep, mood, gut, metabolic, and/or multi-benefits formulations.
It's the two-way link between the gut and the body's stress response. Chronic stress disrupts the gut microbiome, and a disrupted gut amplifies the stress response, so each feeds the other in a downward spiral.
Most ingredients act on one side only: adaptogens on the stress response, probiotics on the gut. ThymoQuin® is the one ingredient clinically studied to support both at once, at a single 500 mg daily dose.
ThymoQuin® belongs in the adaptogen category alongside ingredients such as ashwagandha and L-theanine, but it works differently. Beyond supporting cortisol balance through the HPA axis, it also supports gut balance. That second point of action is the differentiator: ThymoQuin® works on the stress response and on the gut that feeds back into it.
ThymoQuin®, a botanical oil, has two randomized, placebo-controlled trials on stress outcomes:
In the 8-week Talbott 2026 trial, ThymoQuin® was evaluated for cortisol balance, sleep quality, and vigor in the same group of participants. Participants showed improvements in all three, including a 31% improvement in sleep quality.
Yes. In the Talbott 2022 trial, the same participants showed higher beneficial S. thermophilus levels, an 11% improvement in mood (POMS), and a 44% reduction in salivary cortisol within three weeks. Because gut, mood, and stress outcomes were measured together, ThymoQuin® has direct data for gut-brain axis positioning.
Cortisol changes appeared within three weeks. Sleep and resilience outcomes were measured at eight weeks. Consistent daily use matters.
No. It's cold-pressed, full-spectrum, and standardized to at least 3% thymoquinone, with free fatty acids no more than 1.25%, controlled p-cymene, compliance with the USP monograph standard, and clinical research on the actual ingredient.
Yes. Pair it with sleep, movement, a fiber-rich diet, and recovery time. Consult a healthcare professional before starting any new supplement.
*These statements have not been evaluated by the FDA. ThymoQuin is not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before starting a new supplement.